Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3874
Source ID: NCT02009410
Associated Drug: Creon
Title: A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2
Acronym:
Status: WITHDRAWN
Study Results: NO
Results:
Conditions: Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2
Interventions: DRUG: Creon|DRUG: Creon 25000 matching Placebo
Outcome Measures: Primary: Recovery rate of 13CO2 (carbon dioxide with stable isotope of carbon), from baseline up to the week 12 visit | Secondary: Change in nutritional parameters, fat soluble vitamins (D and E), retinol-binding protein, albumin, pre-albumin, magesium and calcium will be measured., from baseline up to the week 12 visit|Change in HbA1c, from baseline up to the week 12 visit|Change in quality of life assessed via a questionnaire Gastrointestinal-Quality of Life Index (GIQL), from baseline up to the week 12 visit|Change in clinical global impression of disease symptoms, disease symptoms will be rated by the subject according a rating scale, from baseline up to the week 12 visit | Other: vital signs, blood pressure and heart rate, body weight and BMI, from baseline up to the week 12 visit|routine safety laboratory, Hematology, biochemistry and a urine pregnancy test will be performed, from baseline up to the week 12 visit
Sponsor/Collaborators: Sponsor: Abbott | Collaborators: Nuvisan|Datamap|ClinIntel|Catalent
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 0
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2013-11
Completion Date: 2014-08
Results First Posted:
Last Update Posted: 2014-06-20
Locations: Site reference no. 113456, Bochum, 44789, Germany|Site reference no. 113477, Frankfurt, 60594, Germany|Site reference no. 113476, Pohlheim, 35415, Germany|Site reference no. 113475, Ulm, 89073, Germany|Site reference no. 112519, Madrid, 28034, Spain|Site reference no. 112520, Málaga, 29071, Spain|Site reference no. 112495, Santiago de Compostela, 15706, Spain|Site reference no. 112518, Segovia, 40002, Spain|Site reference no. 112496, Sevilla, 41014, Spain|Site reference no. 112517, Ávila, 05004, Spain
URL: https://clinicaltrials.gov/show/NCT02009410